Clinical Trial Update: Atrovent in Exercise Induced Laryngeal Obstruction (EILO) [Phase 1, Phase 2]

View source ↗

Summary

This document reports that Phase 1 and Phase 2 clinical trials investigating inhaled ipratropium bromide (Atrovent) for exercise-induced laryngeal obstruction h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exercise-induced Laryngeal Obstruction

Drugs mentioned

• Atrovent (ipratropium bromide)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Exercise Induced Laryngeal Obstruction (EILO) | Phase 1, Phase 2 | Status: COMPLETED